biote Corp. ( BTMD ) NASDAQ Global Market

Cena: 4.28 ( 3.38% )

Aktualizacja 06-26 22:00
NASDAQ Global Market
Branża: Medical - Care Facilities
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Care Facilities
Zatrudnienie: 194
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 93%
Ilość akcji: 33 940 400
Debiut giełdowy: 2021-04-28
WWW: https://biote.com
CEO: Ms. Teresa S. Weber
Adres: 1875 West Walnut Hill Lane
Siedziba: 75038 Irving
ISIN: US0906831039
Opis firmy:

Biote Corp. działa w branży budowania praktyk medycznych w przestrzeni optymalizacji hormonalnej. Firma oferuje platformę dla lekarzy certyfikowanych biotem do optymalizacji nierównowagi w poziomie hormonu, witaminy i minerałów pacjenta, a także przepisywanie bioidentical hormon i zalecania suplementów diety. Sprzedaje również suplementy dietetyczne marki bioty; oraz sterylne zestawy do wstawienia granulatu dla mężczyzn i kobiet. Firma została założona w 2011 roku i ma siedzibę w Irvine w Teksasie.

Wskaźniki finansowe
Kapitalizacja (USD) 163 902 296
Aktywa: 101 252 000
Cena: 4.28
Wskaźnik Altman Z-Score: 1.8
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: 7.4
Ilość akcji w obrocie: 93%
Średni wolumen: 157 056
Ilość akcji 38 294 929
Wskaźniki finansowe
Przychody TTM 193 060 000
Zobowiązania: 228 076 000
Przedział 52 tyg.: 3.04 - 8.44
Piotroski F-Score: 7
Silny (dobra jakość finansowa)
EPS: 0.6
P/E branży: 23.4
Beta: 0.944
Raport okresowy: 2025-08-06
WWW: https://biote.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Ms. Mary Elizabeth Conlon Vice President of Business Development, General Counsel & Corporate Secretary 552 360 1981
Mr. Marc D. Beer Executive Chairman 470 180 1965
Ms. Teresa S. Weber Chief Executive Officer & Director 1 058 000 1953
Mr. Robert C. Peterson Chief Financial Officer 0 1977
Mr. James Elliott Gibbs II Chief People Officer 0 0
Dr. Cory Rice D.O. Chief Clinical Advisor & Member of Medical Advisory Board 0 0
Mr. Richard Kevin Key Chief Digital Officer 0 1971
Mr. Jade Beutler Head of Nutraceuticals 0 1963
Mr. John J. Olsen Chief Information Officer 0 1957
Wiadomości dla biote Corp.
Tytuł Treść Źródło Aktualizacja Link
biote Corp. (BTMD) Q1 2025 Earnings Call Transcript biote Corp. (NASDAQ:BTMD ) Q1 2025 Earnings Call May 7, 2025 5:00 PM ET Company Participants Szymon Serowiecki - Investor Relations Bret Christensen - Chief Executive Officer Bob Peterson - Chief Financial Officer Marc Beer - Executive Chairman Conference Call Participants Kaumil Gajrawala - Jefferies Les Sulewski - Truist Jonna Kim - TD Cowen Jeff Van Sinderen - B. Riley George Kelly - ROTH Capital Partners Operator Hello, and welcome to the biote First Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-05-11 06:55:36 Czytaj oryginał (ang.)
Biote Corp. (BTMD) Q1 Earnings and Revenues Surpass Estimates Biote Corp. (BTMD) came out with quarterly earnings of $0.08 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.23 per share a year ago. zacks.com 2025-05-07 22:41:08 Czytaj oryginał (ang.)
Biote Announces Purchase of Shares by Directors and CEO IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that several members of its Board of Directors, along with CEO Bret Christensen, have made open market purchases of Biote's common stock, acquiring an aggregate of approximately 260,000 shares. Marc Beer, Biote Executive Chairman, said, "These share purchase. businesswire.com 2025-03-18 19:30:00 Czytaj oryginał (ang.)
biote Corp. (BTMD) Q4 2024 Earnings Call Transcript biote Corp. (NASDAQ:BTMD ) Q4 2024 Earnings Conference Call March 12, 2025 5:00 PM ET Corporate Participants Szymon Serowiecki - Investor Relations Mark Beard - Executive Chairman Bret Christensen - Chief Executive Officer Bob Peterson - Chief Financial Officer Conference Call Participants Les Sulewski - Truist Securities Jeff Van Sinderen - B. Riley George Kelly - ROTH Capital Partners Alex Fuhrman - Craig-Hallum Capital Group Operator Good day, and welcome to the Biote Fourth Quarter 2024 Earnings Conference Call. seekingalpha.com 2025-03-12 23:33:03 Czytaj oryginał (ang.)
Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 12, 2025, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conf. businesswire.com 2025-02-26 18:05:00 Czytaj oryginał (ang.)
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year? Here is how biote Corp. (BTMD) and Doximity (DOCS) have performed compared to their sector so far this year. zacks.com 2024-12-18 12:40:24 Czytaj oryginał (ang.)
Should Value Investors Buy biote Corp. (BTMD) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-12-16 18:36:08 Czytaj oryginał (ang.)
Does biote Corp. (BTMD) Have the Potential to Rally 43.89% as Wall Street Analysts Expect? The mean of analysts' price targets for biote Corp. (BTMD) points to a 43.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com 2024-12-04 12:56:12 Czytaj oryginał (ang.)
Are Investors Undervaluing biote Corp. (BTMD) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-29 12:40:41 Czytaj oryginał (ang.)
biote Corp. (BTMD) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? After losing some value lately, a hammer chart pattern has been formed for biote Corp. (BTMD), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term. zacks.com 2024-11-22 12:56:18 Czytaj oryginał (ang.)
Wall Street Analysts Predict a 76.99% Upside in biote Corp. (BTMD): Here's What You Should Know The average of price targets set by Wall Street analysts indicates a potential upside of 77% in biote Corp. (BTMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com 2024-11-18 13:00:39 Czytaj oryginał (ang.)
Is biote Corp. (BTMD) Stock Undervalued Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-13 12:45:38 Czytaj oryginał (ang.)
biote Corp. (BTMD) Q3 2024 Earnings Call Transcript biote Corp. (NASDAQ:BTMD ) Q3 2024 Earnings Call November 12, 2024 5:00 PM ET Company Participants Szymon Serowiecki - Investor Relations Terry Weber - Chief Executive Officer Bob Peterson - Chief Financial Officer Conference Call Participants Jonna Kim - Cowen Jeff Van Sinderen - B. Riley Kaumil Gajrawala - Jefferies Les Sulewski - Truist Securities George Kelly - ROTH Capital Partners Operator Welcome to the biote Third Quarter 2024 Earnings Conference Call. seekingalpha.com 2024-11-13 04:56:29 Czytaj oryginał (ang.)
Biote Corp. (BTMD) Beats Q3 Earnings Estimates Biote Corp. (BTMD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to loss of $0.11 per share a year ago. zacks.com 2024-11-12 21:15:49 Czytaj oryginał (ang.)
Wall Street Analysts See an 88.04% Upside in biote Corp. (BTMD): Can the Stock Really Move This High? The consensus price target hints at an 88% upside potential for biote Corp. (BTMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-11-01 12:56:10 Czytaj oryginał (ang.)
Is biote Corp. (BTMD) a Great Value Stock Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-10-28 12:46:22 Czytaj oryginał (ang.)
biote Corp. (BTMD) Q2 2024 Earnings Call Transcript biote Corp. (NASDAQ:BTMD ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Szymon Serowiecki – Investor Relations Terry Weber – Chief Executive Officer Bob Peterson – Chief Financial Officer Conference Call Participants Les Sulewski – Truist Securities Jonna Kim – TD Cowen Richard Magnusen – B. Riley Securities George Kelly – ROTH Capital Kaumil Gajrawala – Jefferies Operator Good day, and welcome to the Biote Second Quarter 2024 Earnings Conference Call. seekingalpha.com 2024-08-10 18:42:08 Czytaj oryginał (ang.)
Buy These 4 Stocks With Rising Cash Flows for Big Gains Cash indicates a company's true financial health. It is the key to its existence, development and success. zacks.com 2024-08-08 13:10:32 Czytaj oryginał (ang.)
biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable biote Corp. (BTMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. zacks.com 2024-07-25 13:50:53 Czytaj oryginał (ang.)
Buy 4 Stocks With Rising Cash Flows to Enrich Your Portfolio Achieving profit is, no doubt, a company's goal, but having a healthy cash flow is imperative to its existence, development and success. So, ASC, TXO, GPRK and BTMD are worth buying. zacks.com 2024-07-24 12:55:44 Czytaj oryginał (ang.)
5 Stocks With Recent Price Strength to Tap Wall Street Rally Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are ADMA, AMSC, BTMD, LINC, CORT. zacks.com 2024-07-17 12:01:44 Czytaj oryginał (ang.)
Wall Street Analysts Think biote Corp. (BTMD) Could Surge 25.44%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 25.4% in biote Corp. (BTMD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com 2024-07-09 14:56:16 Czytaj oryginał (ang.)
biote Corp. (BTMD) is on the Move, Here's Why the Trend Could be Sustainable biote Corp. (BTMD) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. zacks.com 2024-07-09 13:51:53 Czytaj oryginał (ang.)
biote Corp. (BTMD) Surges 10.4%: Is This an Indication of Further Gains? biote Corp. (BTMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term. zacks.com 2024-06-24 08:30:18 Czytaj oryginał (ang.)
Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has signed a binding term sheet with Marci M. Donovitz, stockholder of Biote, to resolve litigation (“Donovitz Litigation”). For $60 million in the aggregate, Biote will repurchase all of the approximately 8.3 million of the Paired Interests and/or Class. businesswire.com 2024-06-20 20:45:00 Czytaj oryginał (ang.)